Pre-Operative Window of ET to Inform RT Decisions (POWER II)
NCT06507618
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
354
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Female
Interventions
DRUG:
Tamoxifen, Letrozole, Anastrozole, or Exemestane
Sponsor
University of Virginia